Yunnan Botanee Bio-Technology Group Co.LTD
SZSE:300957.SZ
72.28 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 948.763 | 1,718.105 | 1,213.087 | 1,696.058 | 1,088.338 | 2,060.722 | 1,063.741 | 1,504.436 | 863.307 | 2,118.412 | 845.764 | 1,241.178 | 808.52 | 1,909.671 | 700.988 | 904.263 | 507.481 | 1,209.504 | 485.446 | 623.012 | 318.526 | 870.783 | 362.23 |
| Cost of Revenue
| 213.745 | 450.665 | 286.852 | 492.818 | 306.202 | 656.165 | 226.284 | 376.67 | 206.28 | 589.857 | 198.648 | 294.17 | 179.358 | 477.213 | 165.907 | 211.135 | 110.912 | 626.06 | 154.15 | 100.562 | 69.307 | 384.514 | 0 |
| Gross Profit
| 735.018 | 1,267.44 | 926.235 | 1,203.24 | 782.136 | 1,404.556 | 837.456 | 1,127.765 | 657.027 | 1,528.554 | 647.116 | 947.009 | 629.163 | 1,432.458 | 535.08 | 693.129 | 396.569 | 583.444 | 331.296 | 522.45 | 249.219 | 486.269 | 362.23 |
| Gross Profit Ratio
| 0.775 | 0.738 | 0.764 | 0.709 | 0.719 | 0.682 | 0.787 | 0.75 | 0.761 | 0.722 | 0.765 | 0.763 | 0.778 | 0.75 | 0.763 | 0.767 | 0.781 | 0.482 | 0.682 | 0.839 | 0.782 | 0.558 | 1 |
| Reseach & Development Expenses
| 57.912 | 95.425 | 85.456 | 76.982 | 32.647 | 111.373 | 73.066 | 74.925 | 33.955 | 128.244 | 44.944 | 50.514 | 30.997 | 44.74 | 24.533 | 21.107 | 22.841 | 16.041 | 21.871 | 14.253 | 11.276 | 0 | 0 |
| General & Administrative Expenses
| 117.988 | -110.801 | 271.387 | -7.479 | 75.651 | -67.626 | 173.122 | 4.455 | 66.632 | 140.412 | 144.986 | -3.663 | 61.31 | -22.886 | 110.154 | -7.013 | 40.557 | 42.731 | 43.774 | -155.858 | 33.759 | 0 | 0 |
| Selling & Marketing Expenses
| 531.639 | 293.329 | 938.414 | 764.533 | 512.65 | 1,005.101 | 507.39 | 686.247 | 410.938 | 710.266 | 406.19 | 543.183 | 388.242 | 702.965 | 340.478 | 404.301 | 233.025 | 441.18 | 190.981 | 330.835 | 144.137 | 0 | 0 |
| SG&A
| 649.628 | 182.528 | 1,209.802 | 844.877 | 589.054 | 1,151.021 | 680.512 | 690.702 | 477.57 | 844.24 | 551.176 | 539.52 | 449.551 | 680.079 | 450.632 | 397.288 | 273.582 | 497.554 | 230.014 | 174.977 | 177.895 | 0 | 0 |
| Other Expenses
| -22.352 | 838.744 | -2.86 | -8.695 | 1.522 | -9.824 | -1.215 | -0.13 | 2.964 | -56.557 | -79.46 | 83.754 | 6.051 | 3.288 | 2.806 | -3.955 | 0.028 | -188.022 | -421.479 | -2.561 | -1.619 | -206.832 | -292.954 |
| Operating Expenses
| 685.187 | 1,116.697 | 994.737 | 930.553 | 620.179 | 1,272.218 | 669.898 | 809.294 | 514.489 | 915.927 | 516.661 | 673.788 | 486.599 | 867.235 | 425.329 | 470.98 | 301.015 | -188.022 | -421.479 | 392.95 | 184.478 | -206.832 | -292.954 |
| Operating Income
| 49.831 | 150.743 | -68.502 | 272.687 | 161.957 | 132.338 | 138.997 | 317.246 | 180.181 | 612.628 | 96.192 | 291.288 | 129.568 | 594.667 | 103.559 | 218.982 | 98.501 | 395.422 | 63.968 | 128.193 | 62.119 | 279.437 | 69.275 |
| Operating Income Ratio
| 0.053 | 0.088 | -0.056 | 0.161 | 0.149 | 0.064 | 0.131 | 0.211 | 0.209 | 0.289 | 0.114 | 0.235 | 0.16 | 0.311 | 0.148 | 0.242 | 0.194 | 0.327 | 0.132 | 0.206 | 0.195 | 0.321 | 0.191 |
| Total Other Income Expenses Net
| -7.149 | -5.6 | -2.583 | -2.184 | -5.752 | -1.599 | -1.215 | -0.13 | -6.211 | 1.361 | 36.785 | -0.942 | 46.985 | 3.288 | 2.806 | -3.955 | 0.028 | -0.467 | 0.207 | 0.016 | -1.619 | 0.148 | 0.064 |
| Income Before Tax
| 42.682 | 145.143 | -71.085 | 333.013 | 195.09 | 232.821 | 137.782 | 317.116 | 173.969 | 613.989 | 132.977 | 290.346 | 176.553 | 597.955 | 106.365 | 215.027 | 98.53 | 394.956 | 64.175 | 128.209 | 60.5 | 279.585 | 69.339 |
| Income Before Tax Ratio
| 0.045 | 0.084 | -0.059 | 0.196 | 0.179 | 0.113 | 0.13 | 0.211 | 0.202 | 0.29 | 0.157 | 0.234 | 0.218 | 0.313 | 0.152 | 0.238 | 0.194 | 0.327 | 0.132 | 0.206 | 0.19 | 0.321 | 0.191 |
| Income Tax Expense
| 11.471 | 54.866 | -0.023 | 36.256 | 22.508 | 45.822 | 13.284 | 31.547 | 18.954 | 78.964 | 11.54 | 41.692 | 31.136 | 89.649 | 15.693 | 28.956 | 19.515 | 66.718 | 9.248 | 22.045 | 6.549 | 54.591 | 8.09 |
| Net Income
| 28.341 | 88.285 | -68.999 | 306.923 | 176.845 | 177.605 | 129.178 | 291.747 | 158.265 | 534.027 | 122.262 | 249.06 | 145.983 | 507.671 | 90.236 | 186.422 | 78.594 | 328.237 | 54.926 | 106.45 | 53.895 | 224.993 | 61.249 |
| Net Income Ratio
| 0.03 | 0.051 | -0.057 | 0.181 | 0.162 | 0.086 | 0.121 | 0.194 | 0.183 | 0.252 | 0.145 | 0.201 | 0.181 | 0.266 | 0.129 | 0.206 | 0.155 | 0.271 | 0.113 | 0.171 | 0.169 | 0.258 | 0.169 |
| EPS
| 0.07 | 0.214 | -0.16 | 0.73 | 0.42 | 0.42 | 0.31 | 0.69 | 0.37 | 1.26 | 0.29 | 0.59 | 0.34 | 1.42 | 0.25 | 0.52 | 0.22 | 0.92 | 0.15 | 0.3 | 0.15 | 0.63 | 0.17 |
| EPS Diluted
| 0.07 | 0.214 | -0.16 | 0.73 | 0.42 | 0.42 | 0.3 | 0.69 | 0.37 | 1.26 | 0.28 | 0.58 | 0.34 | 1.42 | 0.25 | 0.52 | 0.22 | 0.92 | 0.15 | 0.3 | 0.15 | 0.63 | 0.17 |
| EBITDA
| 46.576 | 150.712 | -65.859 | 393.784 | 181.341 | 282.759 | 187.323 | 355.679 | 212.533 | 526.267 | 163.76 | 317.667 | 203.469 | 602.142 | 113.897 | 230.045 | 113.547 | 402.197 | 71.071 | 133.572 | 66.312 | -570.694 | 362.23 |
| EBITDA Ratio
| 0.049 | 0.088 | -0.054 | 0.232 | 0.167 | 0.137 | 0.176 | 0.236 | 0.246 | 0.248 | 0.194 | 0.256 | 0.252 | 0.315 | 0.162 | 0.254 | 0.224 | 0.333 | 0.146 | 0.214 | 0.208 | -0.655 | 1 |